Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance
Shuai Wang, Saiqi Wang, Qiu‐Xu Teng, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 21, pp. 16187-16204
Closed Access | Times Cited: 24

Showing 24 citing articles:

Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 141
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update
Kritika Engle, Gautam Kumar
European Journal of Medicinal Chemistry (2022) Vol. 239, pp. 114542-114542
Closed Access | Times Cited: 109
Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review
Jinyun Dong, Yuan Li, Can Hu, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108488-108488
Closed Access | Times Cited: 58
Small-molecule MDM2 inhibitors in clinical trials for cancer therapy
Shuai Wang, Fen‐Er Chen
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114334-114334
Closed Access | Times Cited: 63
Triazole-fused pyrimidines in target-based anticancer drug discovery
Xing‐Jie Dai, Lei-Peng Xue, Shi‐Kun Ji, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115101-115101
Closed Access | Times Cited: 31
Structural modification strategies of triazoles in anticancer drug development
Qianwen Guan, Ziming Gao, Yuting Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116578-116578
Closed Access | Times Cited: 8
Design, synthesis, and biological evaluation of β-carboline derivatives as ABCB1 inhibitors for reversing multidrug resistance
Yuanyuan Wang, Nanjin Ding, Yunpeng Zhao, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117390-117390
Closed Access
Simplified Derivatives of Tetrandrine as Potent and Specific P-gp Inhibitors to Reverse Multidrug Resistance in Cancer Chemotherapy
Rong Zeng, Xiu‐Ming Yang, Hongwei Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 6, pp. 4086-4105
Closed Access | Times Cited: 20
Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor
Saiqi Wang, Qiu‐Xu Teng, Shuai Wang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 8, pp. 3263-3280
Open Access | Times Cited: 22
Imidazo[1,2-a]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance
Hui Li, Shenglie Zhang, Yan-Han Jia, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2804-2831
Closed Access | Times Cited: 12
Iridium-Catalyzed Asymmetric Cascade Allylation/Retro-Claisen Reaction
Zhiyuan Yi, Lu Xiao, Xin Chang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 43, pp. 20025-20034
Closed Access | Times Cited: 19
Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistance
Xiang-Jing Fu, Na Li, Ji Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116761-116761
Closed Access | Times Cited: 2
Therapeutic implication of carbon monoxide in drug resistant cancers
Qingbin Cui, Xiao-Lan Liang, Jing‐Quan Wang, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115061-115061
Closed Access | Times Cited: 12
Concise Total Synthesis of Dysoxylactam A and a Simplified Analog
Guan‐Zhou Yang, Lei Wang, Yao‐Yue Fan, et al.
Chinese Journal of Chemistry (2022) Vol. 40, Iss. 17, pp. 2027-2034
Closed Access | Times Cited: 11
Proapoptotic effect of WS-299 induced by NOXA accumulation and NRF2-counterbalanced oxidative stress damage through targeting RBX1-UBE2M interaction in gastric cancers
Ting Ma, Qianqian Song, Bing Cheng, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107142-107142
Closed Access | Times Cited: 1
Discovery of new tricyclic spiroindole derivatives as potent P-glycoprotein inhibitors for reversing multidrug resistance enabled by a synthetic methodology-based library
Tao Yu, Rong Zeng, Yu Guan, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1675-1685
Closed Access | Times Cited: 1
Novel pyxinol amide derivatives bearing an aliphatic heterocycle as P-glycoprotein modulators for overcoming multidrug resistance
Liping Yu, Ruiyin Ren, Shuang Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116466-116466
Closed Access | Times Cited: 1
Synthesis of Fused Pyrimidines from Azole Amines and Their Biological Activity
Yumeng Zhuang, Xianzhang Wang, Bowen Liu, et al.
European Journal of Organic Chemistry (2024) Vol. 27, Iss. 43
Closed Access | Times Cited: 1
Discovery of a novel highly potent and low-toxic jatrophane derivative enhancing the P-glycoprotein-mediated doxorubicin sensitivity of MCF-7/ADR cells
Ayitila Maimaitijiang, Bianlin Wang, Hequn Yang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114822-114822
Closed Access | Times Cited: 6
Synthesis, antiproliferative and anti-MDR activities of lathyrane diterpene derivatives based on configuration inversion strategy
Yao Xiao, Wan-Sheng Ji, Wenke Jin, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106329-106329
Closed Access | Times Cited: 6
Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential
Zhi Xu, Li Wang, Hongyan Hu
Archiv der Pharmazie (2024)
Closed Access
Lathyrane diterpenoids with multidrug resistance reversal activity from the tubers of Euphorbia antiquorum
Ren‐Fen Ma, Qian Wu, Hu Liu, et al.
Phytochemistry (2024) Vol. 228, pp. 114233-114233
Closed Access
Cell-Based Screen Identifies a Highly Potent and Orally Available ABCB1 Modulator for Treatment of Multidrug Resistance
Shuai Wang, Saiqi Wang, Xiaobing Chen, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Acquired resistance to tyrosine kinase targeted therapy: mechanism and tackling strategies
Defa Wu, Qian Sun, Hongjun Tang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101176-101176
Closed Access
Page 1

Scroll to top